Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 75.11M P/E - EPS this Y 1.40% Ern Qtrly Grth -
Income -16.91M Forward P/E -4.03 EPS next Y 25.40% 50D Avg Chg 7.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -12.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -57.00%
Recommedations 2.50 Quick Ratio 6.45 Shares Outstanding 26.56M 52W Low Chg 159.00%
Insider Own 29.25% ROA -69.75% Shares Float 19.27M Beta -0.99
Inst Own 8.49% ROE -113.62% Shares Shorted/Prior 82.09K/179.67K Price 2.90
Gross Margin - Profit Margin - Avg. Volume 508,666 Target Price 5.00
Oper. Margin - Earnings Date Aug 14 Volume 42,809 Change -4.92%
About Heartbeam, Inc.

HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.

Heartbeam, Inc. News
11/19/24 HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
11/08/24 HeartBeam Inc (BEAT) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges and ...
11/07/24 HeartBeam Reports Third Quarter 2024 Results
10/31/24 Spotlight On US Penny Stocks In October 2024
10/31/24 HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time
10/25/24 HeartBeam, Inc. (BEAT): A Bull Case Theory
10/24/24 HeartBeam Named "Rising Star" at the 6th Annual Digital Health Hub Foundation Awards
10/17/24 HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization
09/24/24 HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist
09/14/24 Is HeartBeam (NASDAQ:BEAT) In A Good Position To Invest In Growth?
09/10/24 HeartBeam Names Timothy Cruickshank as Chief Financial Officer
08/14/24 HeartBeam Reports Second Quarter 2024 Results
08/01/24 HeartBeam to Host Second Quarter 2024 Results Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
07/01/24 HeartBeam Added to Russell Microcap® Index
07/01/24 Anumana sees results from pulmonary hypertension detecting algorithm trial
05/31/24 Caristo touts study showing accuracy of its CaRi-Heart technology
08:22 AM HeartBeam’s AI device outperforms experts in detecting atrial flutter
05/20/24 HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias
05/13/24 HeartBeam, Inc. (NASDAQ:BEAT) Q1 2024 Earnings Call Transcript
05/13/24 HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program
BEAT Chatroom

User Image dnsfw Posted - 30 minutes ago

$BEAT didnt stay over $3 very long, but not a bad day. Maybe good news to come...

User Image Oil_Pal Posted - 58 minutes ago

$BEAT 🚀🚀🚀 This movement is golden

User Image dnsfw Posted - 3 hours ago

$BEAT Oh was this a pump/dump today re-Maryna post lol

User Image CocaKolla Posted - 4 hours ago

$BEAT on the move

User Image dnsfw Posted - 4 hours ago

$BEAT >O_O> $$$

User Image Rolltide2020 Posted - 4 hours ago

$EBS $AI $BEAT

User Image afterhoursearnings Posted - 5 hours ago

$BEAT 👀

User Image Peterman25 Posted - 5 hours ago

$BEAT Did they get a mention on a business news channel this morning? That’s what usually moves this on zero news. That or somebody knows approval is around the corner. Or, they want to squeeze it. I’ve noticed recently how much it moves up on little volume. Movement on no news is suspect. Then again volume before price. Just some 🤔🤔.

User Image Peterman25 Posted - 5 hours ago

@dnsfw Yeah, our little $BEAT is showing a pulse. Hmmm.

User Image dnsfw Posted - 5 hours ago

$BEAT hmmm

User Image NewEnglandJournalMed Posted - 1 day ago

$BEAT True snap shot of this stock! Even though it is not pharmaceutit’s a device…

User Image Oil_Pal Posted - 2 days ago

$BEAT on the move 😋

User Image NetworkNewsWire Posted - 2 days ago

$BEAT Presents Positive Data for Groundbreaking Technology at AHA Conference https://ibn.fm/ugTDE

User Image dnsfw Posted - 2 days ago

$BEAT RICHard FERRARI: Executive Chairman of the Board of Directors. Lmao, buy more

User Image nyse1929a Posted - 2 days ago

$BEAT https://www.businesswire.com/news/home/20241119868131/en/

User Image Rolltide2020 Posted - 2 days ago

$BEAT Leaked approval?

User Image turuguru Posted - 2 days ago

$BEAT presented studies had solid results, will look into details later. They also have new front at their site and some other changes. I like the new slogan.

User Image Rolltide2020 Posted - 2 days ago

$BEAT Interesting PM action.

User Image gapureau Posted - 3 days ago

$BEAT Too bad this company is only trying to help those with heart issues. Stocks in the news for last few days seeing 10's and 100's% gains seem to all be in the Biotech area addressing Cancer, Diabetes, etc. Maybe good news here very soon.

User Image Stocksrockman Posted - 5 days ago

$ZONE socials are on fire This means one thing BOOOOOM!!!! $lvlu bottom bounce $LRHC looks like a run is coming $BEAT and $VSME bottoms

User Image Rolltide2020 Posted - 5 days ago

$BEAT Is it too much to hope that they will be on fda clearance list Monday am while also having a booth at American Heart Association conference?

User Image turuguru Posted - 1 week ago

$BEAT

User Image txmdforlife Posted - 1 week ago

$BEAT what’s going on? We’ve been on a slump for the last week.

User Image DrDz Posted - 1 week ago

@Rolltide2020 $BEAT is a stay away type of company. Dead money.

User Image Rolltide2020 Posted - 1 week ago

$EBS $GLSI $BEAT $RKLB Four winners just scratching the surface of short term and long term potential. Look for my repost before end of year.

User Image DrDz Posted - 1 week ago

@NetworkNewsWire what is the difference between questions and clarifications asked by the FDA you mention in your piece around ‘progress’ of $BEAT ?

User Image NetworkNewsWire Posted - 1 week ago

BioMedNewsBreaks — $BEAT Advances Toward Commercialization of Cardiac Care Technology with FDA Submissions and Key Leadership Appointments https://ibn.fm/YGrBX

User Image Algofun Posted - 1 week ago

$BEAT spike AF

User Image SpyVsSpy2 Posted - 1 week ago

$BEAT lot of complaints about no FDA clearance but that isn’t dictated by the company or its impatient investors. I’ve invested in many companies who’ve been through this and the patient will be rewarded if the product has merit which I believe it does. The biggest wins I’ve had have been based on this premise.

User Image Peterman25 Posted - 1 week ago

$BEAT Yup. Big giant nothingburger on that call. Same updates. And we can’t discuss anything in detail. 🙄

Analyst Ratings
Benchmark Speculative Buy May 13, 24
Benchmark Speculative Buy Mar 25, 24
Benchmark Speculative Buy Nov 16, 23
Benchmark Speculative Buy Aug 24, 23
Alliance Global Partners Buy May 19, 23
Benchmark Speculative Buy May 19, 23
Benchmark Speculative Buy Mar 21, 23
Alliance Global Partners Buy Dec 2, 22
Benchmark Speculative Buy Dec 20, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
de Urioste George Director Director Sep 29 Sell 2.06 5,500 11,330 36,129 10/03/23
de Urioste George Director Director Sep 27 Sell 2.08 9,834 20,455 41,629 09/29/23
de Urioste George Director Director Sep 22 Sell 2.15 7,393 15,895 51,463 09/27/23
de Urioste George Director Director Sep 20 Sell 2.44 983 2,399 58,856 09/22/23
de Urioste George Director Director Sep 15 Sell 2.45 9,269 22,709 59,839 09/19/23
de Urioste George Director Director Sep 13 Sell 2.01 10,000 20,100 69,108 09/15/23
Brounstein Richard Chief Financial Offi.. Chief Financial Officer Nov 02 Option 0.0003 759 111,164 11/02/22
Brounstein Richard Chief Financial Offi.. Chief Financial Officer Sep 02 Option 0.0003 757 109,645 09/02/22
Brounstein Richard Chief Financial Offi.. Chief Financial Officer Aug 02 Option 0.0003 757 108,888 08/02/22
Brounstein Richard Chief Financial Offi.. Chief Financial Officer Jul 05 Option 0.0003 757 108,131 07/06/22
Brounstein Richard Chief Financial Offi.. Chief Financial Officer May 02 Option 0.0003 757 106,617 05/02/22
BROUNSTEIN RICHARD D CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Nov 11 Option 4.2 29,197 122,627 92,075 11/15/21
BROUNSTEIN RICHARD D CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER Nov 11 Buy 5.99 5,000 29,950 97,075 11/15/21
Ortigas-Wedekind Marga Director Director Nov 11 Option 4.2 7,824 32,861 7,824 11/15/21
Ortigas-Wedekind Marga Director Director Nov 11 Buy 5.99 9,000 53,910 16,824 11/15/21
Elfrink Willhem Director Director Nov 11 Option 4.2 332,407 1,396,109 437,861 11/15/21